Mirae Asset Global Etfs Holdings Ltd. Corcept Therapeutics Inc Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 40,675 shares of CORT stock, worth $2.4 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40,675Holding current value
$2.4 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CORT
# of Institutions
322Shares Held
88.4MCall Options Held
1.07MPut Options Held
822K-
Black Rock Inc. New York, NY16.5MShares$977 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.55MShares$564 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.24MShares$487 Million11.51% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.91MShares$408 Million0.4% of portfolio
-
Parallel Advisors, LLC3.82MShares$225 Million3.2% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $6.33B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...